Former Navy SEAL Jon Dalton, who served in Iraq and Afghanistan, now leads the Nevada Coalition for Psychedelic Medicines. Despite initially being against illegal drugs, Dalton found hope in Mexico, where psychedelic drugs are not scheduled or exist in a legal gray area that allows clinics to operate. He completed a treatment with ibogaine, a powerful West African plant alkaloid used in part to treat post-traumatic stress disorder and traumatic brain injury. The drug is currently classified as Schedule I substances under the Controlled Substances Act. However, a growing body of supporters is pushing for a reclassification and the exploration of these drugs in medical settings. President Donald Trump recently signed an executive order that could help people with serious mental health issues access psychedelic therapies. The order includes expediting its review of psychedelic compounds with breakthrough therapy designations, expanding collaboration with the Department of Veterans Affairs on psychedelic-assisted therapy for veterans with PTSD, depression, and providing $50 million for state-level research.